P3 Health Partners Income from Continuous Operations 2020-2025 | PIII

P3 Health Partners income from continuous operations from 2020 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
P3 Health Partners Annual Income from Continuous Operations
(Millions of US $)
2024 $-310
2023 $-186
2022 $-1,562
2021 $-204
2020 $-31
2019 $-42
P3 Health Partners Quarterly Income from Continuous Operations
(Millions of US $)
2025-06-30 $-44
2025-03-31 $-44
2024-12-31 $-129
2024-09-30 $-103
2024-06-30 $-29
2024-03-31 $-50
2023-12-31 $-69
2023-09-30 $-37
2023-06-30 $-28
2023-03-31 $-52
2022-12-31 $-532
2022-09-30 $-65
2022-06-30 $-903
2022-03-31 $-61
2021-12-31 $-118
2021-09-30 $-32
2021-06-30 $-29
2021-03-31 $-25
2020-12-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.053B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.602B 59.29
Tempus AI (TEM) United States $13.186B 0.00
Doximity (DOCS) United States $12.437B 55.33
Hims & Hers Health (HIMS) United States $9.717B 79.61
IRhythm Technologies (IRTC) United States $5.323B 0.00
Hinge Health (HNGE) United States $4.319B 0.00
Inspire Medical Systems (INSP) United States $2.748B 40.40
Privia Health (PRVA) United States $2.626B 194.54
Heartflow (HTFL) $2.422B 0.00
Phreesia (PHR) United States $1.808B 0.00
Enovis (ENOV) United States $1.771B 9.36
10x Genomics (TXG) United States $1.752B 0.00
Omnicell (OMCL) United States $1.520B 29.28
Schrodinger (SDGR) United States $1.438B 0.00
Azenta (AZTA) United States $1.410B 61.52
Clover Health Investments (CLOV) United States $1.356B 0.00
Claritev (CTEV) United States $1.180B 0.00
Evolent Health (EVH) United States $1.140B 0.00
Fulgent Genetics (FLGT) United States $0.659B 0.00
Zepp Health (ZEPP) Netherlands $0.570B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.474B 0.00
Talkspace (TALK) United States $0.445B 132.75
Butterfly Network (BFLY) United States $0.390B 0.00
Carlsmed (CARL) United States $0.380B 0.00
TruBridge (TBRG) United States $0.298B 52.29
Outset Medical (OM) United States $0.244B 0.00
Health Catalyst (HCAT) United States $0.235B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
Nyxoah SA (NYXH) Belgium $0.220B 0.00
KORU Medical Systems (KRMD) United States $0.194B 0.00
CapsoVision (CV) United States $0.187B 0.00
MDxHealth SA (MDXH) Belgium $0.167B 0.00
CareCloud (CCLD) United States $0.135B 6.12
ImmunoPrecise Antibodies (IPA) Canada $0.127B 0.00
American Well (AMWL) United States $0.113B 0.00
EUDA Health Holdings (EUDA) Singapore $0.099B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.071B 0.00
Pulmonx (LUNG) United States $0.068B 0.00
111 (YI) China $0.061B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Precipio (PRPO) United States $0.023B 0.00
PROFUSA (PFSA) United States $0.016B 0.00
Healthcare Triangle (HCTI) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.005B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00